GL1X · GenesisL1 explorer

MolNFT v1 · #107598 · protein

Crystal structure of uch-L5 in complex with inhibitory fragment of INO80G

4UF5 · Ubiquitin carboxyl-terminal hydrolase isozyme L5: “Crystal structure of uch-L5 in complex with inhibitory fragment of INO80G”. X-ray diffraction, 7 pockets (best druggability 0.69). MolNFT v1 #107598 on GenesisL1: 3D structure…

PDB
4UF5
Type
protein
Length
403 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase isozyme L5; Nuclear factor related to…
EC
3.4.19.12
UniProt
Q9Y5K5, Q6P4R8
Pockets
7 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 57% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquitin carboxyl-terminal hydrolase isozyme L5 (EC 3.4.19.12)protein29351% helix, 15% strandQ9Y5K5
BNuclear factor related to kappa-B-binding proteinprotein11074% helix, 0% strandQ6P4R8

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17110.690.7764empty
21500.670.8728empty
33200.650.8036empty
41570.490.7820empty
5790.400.7816empty

Interfaces

1 interface between chains.

  • A–B · 2265 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4UF5 · Crystal structure of UCH-L5 in complex with inhibitory fragment of INO80G · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6P4R8 · AlphaFold monomer V2.0 prediction for nuclear factor related to kappa-B-binding protein… · a predicted model of the same protein · chain B against A, TM-score 0.88
  • Q9Y5K5 · AlphaFold monomer V2.0 prediction for ubiquitin carboxyl-terminal hydrolase isozyme L5… · a predicted model of the same protein · chain A against A, TM-score 0.77

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.